Skip to main content
SpringerLink
Log in
Book cover

High-Density Lipoproteins as Biomarkers and Therapeutic Tools pp 115–261Cite as

Enhancement of HDL by Policosanol

  • Chapter
  • First Online:

  • 246 Accesses

Abstract

It is well established that a higher level of serum HDL-cholesterol is associated with lower incidence of coronary artery disease (Gotto Jr et al. 1978) and increased longevity (Mazzotti et al. 2014; Milman et al. 2014). Policosanol (PCO) supplementation is widely used in Central America and Latin America to treat dyslipidemia and manage cardiovascular burden. PCO is mixture of eight aliphatic primary alcohols refined from sugarcane wax (Saccharum officinarum L.). It is available as an over-the-counter dietary supplement to treat dyslipidemia in some countries. It has been reported that consumption of PCO can significantly reduce serum total cholesterol and LDL-cholesterol levels as well as raise serum HDL-cholesterol (Gouni-Berthold and Berthold 2002).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Adhikari P, Hwang KT, Park JN, Kim CK. Policosanol content and composition in perilla seeds. J Agric Food Chem. 2006;54(15):5359–62.

    Article  CAS  PubMed  Google Scholar 

  • Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, et al. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol. 2012;4(3):77–83.

    Article  PubMed  PubMed Central  Google Scholar 

  • Andrzejczak D, Gorska D. The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats. Pharmacol Rep. 2014;66(1):68–73.

    Article  CAS  PubMed  Google Scholar 

  • Arai T, Yamashita S, Hirano K-i, Sakai N, Kotani K, Fujioka S, et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb Vasc Biol. 1994;14(7):1129–36.

    Article  CAS  Google Scholar 

  • Arruzazabala ML, Carbajal D, Mas R, Garcia M, Fraga V. Effects of Policosanol on platelet aggregation in rats. Thromb Res. 1993;69(3):321–7.

    Article  CAS  PubMed  Google Scholar 

  • Arruzazabala ML, Carbajal D, Mas R, Molina V, Valdes S, Laguna A. Cholesterol-lowering effects of policosanol in rabbits. Biol Res. 1994;27(3–4):205–8.

    CAS  PubMed  Google Scholar 

  • Arruzazabala ML, Noa M, Menéndez R, Mas R, Carbajal D, Valdes S, et al. Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia. Braz J Med Biol Res. 2000;33(7):835–40.

    Article  CAS  PubMed  Google Scholar 

  • Arruzazabala ML, Molina V, Carbajal D, Fernandez L, Mas R, Castaño G, et al. Effects of D-003, a mixture of very long chain fatty acids purified from sugar cane wax, at 5 and 10 mg/day on platelet aggregation in healthy volunteers. Int J Clin Pharmacol Res. 2005;25(1):29–39.

    CAS  PubMed  Google Scholar 

  • Arul GR. Applications of sugarcane wax and it’s products: a review. 2012

    Google Scholar 

  • Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 Suppl B):9–20.

    PubMed  Google Scholar 

  • Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy. Lipids. 2011;46(10):923–9.

    Article  CAS  PubMed  Google Scholar 

  • Badyal D, Lata H, Dadhich A. Animal models of hypertension and effect of drugs. Indian J Pharmacol. 2003;35(6):349–62.

    CAS  Google Scholar 

  • Baek SA, Jung YH, Lim SH, Park SU, Kim JK. Metabolic profiling in Chinese cabbage (Brassica rapa L. subsp. pekinensis) cultivars reveals that Glucosinolate content is correlated with carotenoid content. J Agric Food Chem. 2016;64(21):4426–34.

    Article  CAS  PubMed  Google Scholar 

  • Banerjee S, Ghoshal S, Porter TD. Activation of AMP-kinase by policosanol requires peroxisomal metabolism. Lipids. 2011;46(4):311–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barkowski RS, Frishman WH. HDL metabolism and CETP inhibition. Cardiol Rev. 2008;16(3):154–62.

    Article  PubMed  Google Scholar 

  • Barrat E, Zair Y, Ogier N, Housez B, Vergara C, Maudet C, et al. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial. Int J Food Sci Nutr. 2013a;64(7):882–9.

    Article  CAS  PubMed  Google Scholar 

  • Barrat E, Zair Y, Sirvent P, Chauveau P, Maudet C, Housez B, et al. Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study. Eur J Nutr. 2013b;52(8):1843–52.

    Article  CAS  PubMed  Google Scholar 

  • Barrios V, Escobar C, Cicero AF, Burke D, Fasching P, Banach M, et al. A nutraceutical approach (Armolipid plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence. Atheroscler Suppl. 2017;24:1–15.

    Article  PubMed  Google Scholar 

  • Barter PJ, Rye KA. Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res. 2012;53(9):1755–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA. 2003;290(15):2030–40.

    Article  CAS  PubMed  Google Scholar 

  • Batista J, Stusser R, Saez F, Perez B. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study. Int J Clin Pharmacol Ther. 1996;34(3):134–7.

    CAS  PubMed  Google Scholar 

  • Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–6.

    Article  CAS  PubMed  Google Scholar 

  • Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA. 2006;295(19):2262–9.

    Article  CAS  PubMed  Google Scholar 

  • Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181(4617):1199.

    Article  CAS  Google Scholar 

  • Botta E, Merono T, Saucedo C, Martin M, Tetzlaff W, Sorroche P, et al. Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritis. Atherosclerosis. 2016;251:438–44.

    Article  CAS  PubMed  Google Scholar 

  • Boyce G, Button E, Soo S, Wellington C. The pleiotropic vasoprotective functions of high density lipoproteins (HDL). J Biomed Res. 2017;

    Google Scholar 

  • Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med. 2004;350(15):1505–15.

    Article  CAS  PubMed  Google Scholar 

  • Butlin M, Qasem A. Large artery stiffness assessment using SphygmoCor technology. Pulse (Basel, Switzerland). 2017;4(4):180–92.

    Google Scholar 

  • Campbell S, Genest J. HDL-C: clinical equipoise and vascular endothelial function. Expert Rev Cardiovasc Ther. 2013;11(3):343–53.

    Article  CAS  PubMed  Google Scholar 

  • Canavaciolo VLG, Gómez CV. “Copycat-policosanols” versus genuine policosanol. Revista CENIC CienciasQuímicas. 2007;38:207–13.

    Google Scholar 

  • Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM, et al. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med. 2010;363(25):2406–15.

    Article  CAS  PubMed  Google Scholar 

  • Carbajal D, Arruzazabala ML, Valdes S, Mas R. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids. 1998;58(1):61–4.

    Article  CAS  PubMed  Google Scholar 

  • Carlomagno G, Pirozzi C, Mercurio V, Ruvolo A, Fazio S. Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2012;22(5):e13–4.

    Article  CAS  PubMed  Google Scholar 

  • Castaño G, Más R, Fernández JC, López LE, Fernández L. A long-term, open-label study of the efficacy and tolerability of policosanol in patients with high global coronary risk. Curr Ther Res. 1999;60(7):379–91.

    Article  Google Scholar 

  • Castaño G, Más R, Fernández JC, Fernández L, Alvarez E, Lezcay M. Efficacy and tolerability of policosanol compared with lovastatin in patients with type II hypercholesterolemia and concomitant coronary risk factors. Curr Ther Res. 2000;61:137–146.

    Article  Google Scholar 

  • Castaño G, Más R, Fernández L, Illnait J, Gámez R, Fernández JC. Comparison of two regimens of policosanol administered at 20 mg/d in patients with type II hypercholesterolemia: a randomized, double-blind, placebo-controlled study. Curr Ther Res. 2001a;62(3):194–208.

    Article  Google Scholar 

  • Castaño G, Mas R, Fernandez JC, Illnait J, Fernandez L, Alvarez E. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerontol A Biol Sci Med Sci. 2001b;56(3):M186–92.

    Article  PubMed  Google Scholar 

  • Castaño G, Más R, Fernández L, Lopez E, Gutierrez JA, Illnait J, et al. Assessment of the effects of D-003, a new antiplatelet and lipid-lowering compound, in healthy volunteers. A phase I clinical study. Drugs R&D. 2002a;3(5):337–48.

    Article  Google Scholar 

  • Castaño G, Mas R, Fernandez JC, Fernandez L, Illnait J, Lopez E. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia. Drugs R&D. 2002b;3(3):159–72.

    Article  Google Scholar 

  • Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, et al. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study. Drugs Exp Clin Res. 2005;31(Suppl):31–44.

    PubMed  Google Scholar 

  • Catrysse L, van Loo G. Inflammation and the metabolic syndrome: the tissue-specific functions of NF-kappaB. Trends Cell Biol. 2017;27(6):417–29.

    Article  CAS  PubMed  Google Scholar 

  • Chantepie S, Bochem AE, Chapman MJ, Hovingh GK, Kontush A. High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity. PLoS One. 2012;7(11):e49336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005;25(2):171–83.

    Article  CAS  PubMed  Google Scholar 

  • Chen SL, Zhang FF, Xu J, Xie DJ, Zhou L, Nguyen T, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension). J Am Coll Cardiol. 2013;62(12):1092–100.

    Article  PubMed  Google Scholar 

  • Cho KH. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 2009a;42(7):393–400.

    Article  CAS  PubMed  Google Scholar 

  • Cho KH. Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol Cells. 2009b;27(3):291–7.

    Article  CAS  PubMed  Google Scholar 

  • Cho KH. Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration. J Gerontol A Biol Sci Med Sci. 2011;66(12):1274–85.

    Article  PubMed  CAS  Google Scholar 

  • Cho KH, Shin DG, Baek SH, Kim JR. Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp Mol Med. 2009;41(2):67–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cho KH, Kim SJ, Yadav D, Kim JY, Kim JR. Consumption of Cuban Policosanol improves blood pressure and lipid profile via enhancement of HDL functionality in healthy women subjects: randomized, double-blinded, and placebo-controlled study. Oxidative Med Cell Longev. 2018a;2018:4809525.

    Google Scholar 

  • Cho KH, Yadav D, Kim SJ, Kim JR. Blood pressure lowering effect of Cuban Policosanol is accompanied by improvement of hepatic inflammation, lipoprotein profile, and HDL quality in spontaneously hypertensive rats. Molecules (Basel, Switzerland). 2018b;23(5):1080.

    Article  CAS  Google Scholar 

  • Cho KH, Yadav D, Park YB, Kim JR. Improvement in lipid profile after Long-term consumption of Policosanol accompanied by reduced oxidation of LDL and aortic stiffness via CETP inhibition in healthy middle-aged women. J Clin Diagn Res. 2019;13:OD12–4.

    Google Scholar 

  • Choi JS, Jeon MH, Moon WS, Moon JN, Cheon EJ, Kim JW, et al. In vivo hair growth-promoting effect of rice bran extract prepared by supercritical carbon dioxide fluid. Biol Pharm Bull. 2014;37(1):44–53.

    Article  CAS  PubMed  Google Scholar 

  • Choi SJ, Park SY, Park JS, Park SK, Jung MY. Contents and compositions of policosanols in green tea (Camellia sinensis) leaves. Food Chem. 2016;204:94–101.

    Article  CAS  PubMed  Google Scholar 

  • Cicero AF, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, et al. Lipid-lowering nutraceuticals in clinical practice: position paper from an international lipid expert panel. Nutr Rev. 2017;75(9):731–67.

    Article  PubMed  Google Scholar 

  • Cilpa-Karhu G, Jauhiainen M, Riekkola ML. Atomistic MD simulation reveals the mechanism by which CETP penetrates into HDL enabling lipid transfer from HDL to CETP. J Lipid Res. 2015;56(1):98–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J. 2006;152(5):982.e1-5.

    Article  PubMed  CAS  Google Scholar 

  • Cuellar LA, Prieto ED, Cabaleiro LV, Garda HA. Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process. Biochim Biophys Acta. 2014;1841(1):180–9.

    Article  CAS  PubMed  Google Scholar 

  • Das M, Wilson CJ, Mei X, Wales TE, Engen JR, Gursky O. Structural stability and local dynamics in disease-causing mutants of human Apolipoprotein A-I: what makes the protein Amyloidogenic. J Mol Biol. 2016;428(2 Pt B):449–62.

    Article  CAS  PubMed  Google Scholar 

  • Davidson MH. Update on CETP inhibition. J Clin Lipidol. 2010;4(5):394–8.

    Article  PubMed  Google Scholar 

  • De Castro-Oros I, Sola R, Valls RM, Brea A, Mozas P, Puzo J, et al. Genetic variants of LDLR and PCSK9 associated with variations in response to Antihypercholesterolemic effects of Armolipid plus with Berberine. PLoS One. 2016;11(3):e0150785.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA. A review of CETP and its relation to atherosclerosis. J Lipid Res. 2004;45(11):1967–74.

    Article  PubMed  CAS  Google Scholar 

  • Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19(2):214–9.

    Article  CAS  PubMed  Google Scholar 

  • Dodani S, Grice DG, Joshi S. Is HDL function as important as HDL quantity in the coronary artery disease risk assessment? J Clin Lipidol. 2009;3(2):70–7.

    Article  PubMed  Google Scholar 

  • Dorfman SE, Smith DE, Osgood DP, Lichtenstein AH. Study of diet-induced changes in lipoprotein metabolism in two strains of Golden-Syrian hamsters. J Nutr. 2003;133(12):4183–8.

    Article  CAS  PubMed  Google Scholar 

  • Dragan S, Serban C, Banach M. Can we change the functionality of HDL cholesterol with nonpharmacological and pharmacological agents? Curr Med Chem. 2014;21(25):2927–46.

    Article  CAS  PubMed  Google Scholar 

  • Dulin MF, Hatcher LF, Sasser HC, Barringer TA. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr. 2006;84(6):1543–8.

    Article  CAS  PubMed  Google Scholar 

  • Dullens SP, Mensink RP, Bragt MC, Kies AK, Plat J. Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J Lipid Res. 2008;49(4):790–6.

    Article  CAS  PubMed  Google Scholar 

  • Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102(7):1065–74.

    Article  CAS  PubMed  Google Scholar 

  • Eghdamian B, Ghose K. Mode of action and adverse effects of lipid lowering drugs. Drugs Today (Barc). 1998;34(11):943–56.

    Article  CAS  Google Scholar 

  • Elseweidy MM, Zein N, Aldhamy SE, Elsawy MM, Saeid SA. Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats. Exp Biol Med (Maywood). 2016;241(17):1943–9.

    Article  CAS  PubMed Central  Google Scholar 

  • Eren E, Yilmaz N, Aydin O. High density lipoprotein and it’s dysfunction. Open Biochem J. 2012;6:78–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eren E, Yilmaz N, Aydin O. Functionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosis. Cholesterol. 2013;2013:792090.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1–11.

    Article  PubMed  Google Scholar 

  • Feig DI. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 2014;26(2):176–85.

    Article  CAS  PubMed  Google Scholar 

  • Feingold KR, Grunfeld C. Effect of inflammation on HDL structure and function. Curr Opin Lipidol. 2016;27(5):521–30.

    Article  CAS  PubMed  Google Scholar 

  • Fernandez S, Mas R, Gamez R, Diaz A, Fernandez J, Deibis Orta S, et al. A pharmacological surveillance study of the tolerability of policosanol in the elderly population. Am J Geriatr Pharmacother. 2004;2(4):219–29.

    Article  CAS  PubMed  Google Scholar 

  • Fouad-Tarazi F, Calcatti J, Christian R, Armstrong R, Depaul M. Blood volume measurement as a tool in diagnosing syncope. Am J Med Sci. 2007;334(1):53–6.

    Article  PubMed  Google Scholar 

  • Francini-Pesenti F, Beltramolli D, Dall’acqua S, Brocadello F. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia. Phytother Res. 2008a;22(3):318–22.

    Article  CAS  PubMed  Google Scholar 

  • Francini-Pesenti F, Brocadello F, Beltramolli D, Nardi M, Caregaro L. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study. Complement Ther Med. 2008b;16(2):61–5.

    Article  CAS  PubMed  Google Scholar 

  • Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb. 2009;16(3):145–54.

    Article  CAS  PubMed  Google Scholar 

  • Fullerton MD, Ford RJ, McGregor CP, LeBlond ND, Snider SA, Stypa SA, et al. Salicylate improves macrophage cholesterol homeostasis via activation of Ampk. J Lipid Res. 2015;56(5):1025–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gámez R, Mendoza S, Más R, Mesa R, Castaño G, Rodriguez B, et al. Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits. Curr Ther Res. 2000;61(7):460–8.

    Article  Google Scholar 

  • Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A. Effects of curcumin on HDL functionality. Pharmacol Res. 2017;119:208–18.

    Article  CAS  PubMed  Google Scholar 

  • García-González V, Mas-Oliva J. Amyloid fibril formation of peptides derived from the C-terminus of CETP modulated by lipids. Biochem Biophys Res Commun. 2013;434(1):54–9.

    Article  PubMed  CAS  Google Scholar 

  • García-González V, Gutierrez-Quintanar N, Mendoza-Espinosa P, Brocos P, Pineiro A, Mas-Oliva J. Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity. J Struct Biol. 2014;186(1):19–27.

    Article  PubMed  CAS  Google Scholar 

  • Gong J, Qin X, Yuan F, Hu M, Chen G, Fang K, et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: a meta-analysis of randomized controlled trials. Mol Nutr Food Res. 2018;62(1):1700280.

    Article  CAS  Google Scholar 

  • González J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: new insights. World J Cardiol. 2014;6(6):353–66.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8–15.

    Article  CAS  PubMed  Google Scholar 

  • Gotto AM Jr, Moon JE. Pharmacotherapies for lipid modification: beyond the statins. Nat Rev Cardiol. 2013;10(10):560.

    Article  CAS  PubMed  Google Scholar 

  • Gotto AM Jr, Miller NE, Oliver MF. High density lipoproteins and atherosclerosis. Amsterdam: Elsevier/North-Holland Biomedical Press; 1978.

    Google Scholar 

  • Gouni-Berthold I, Berthold HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J. 2002;143(2):356–65.

    Article  CAS  PubMed  Google Scholar 

  • Greyling A, De Witt C, Oosthuizen W, Jerling JC. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr. 2006;95(5):968–75.

    Article  CAS  PubMed  Google Scholar 

  • Griffin A. Women’s health and the articulation of policy preferences. Setting the terms of discussion. Ann N Y Acad Sci. 1994;736:205–16.

    Article  CAS  PubMed  Google Scholar 

  • Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–73.

    Article  PubMed  Google Scholar 

  • Guo YL, Xu RX, Zhu CG, Wu NQ, Cui ZP, Li JJ. Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin. Evid Based Complement Alternat Med. 2014;2014:926087.

    PubMed  PubMed Central  Google Scholar 

  • Gupta H, Pawar D, Riva A, Bombardelli E, Morazzoni P. A randomized, double-blind, placebo-controlled trial to evaluate efficacy and tolerability of an optimized botanical combination in the Management of Patients with primary hypercholesterolemia and mixed Dyslipidemia. Phytother Res. 2012;26(2):265–72.

    Article  CAS  PubMed  Google Scholar 

  • Gutstein DE, Krishna R, Johns D, Surks HK, Dansky HM, Shah S, et al. Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction. Clin Pharmacol Ther. 2012;91(1):109–22.

    Article  CAS  PubMed  Google Scholar 

  • Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol B. 1982;71(2):265–9.

    Article  CAS  PubMed  Google Scholar 

  • Haas MJ, Onstead-Haas LM, Szafran-Swietlik A, Kojanian H, Davis T, Armstrong P, et al. Induction of hepatic apolipoprotein A-I gene expression by the isoflavones quercetin and isoquercetrin. Life Sci. 2014;110(1):8–14.

    Article  CAS  PubMed  Google Scholar 

  • Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension (Dallas, Tex: 1979). 2006;47(1):45–50.

    Article  CAS  Google Scholar 

  • Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34(9):1345–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirano M, Nakanishi S, Kubota M, Maeda S, Yoneda M, Yamane K, et al. Low high-density lipoprotein cholesterol level is a significant risk factor for development of type 2 diabetes: data from the Hawaii-Los Angeles-Hiroshima study. J Diab Investig. 2014;5(5):501–6.

    Article  CAS  Google Scholar 

  • Holvoet P, De Keyzer D, Jacobs DR Jr. Oxidized LDL and the metabolic syndrome. Futur Lipidol. 2008;3(6):637–49.

    Article  CAS  Google Scholar 

  • Holzer M, Trieb M, Konya V, Wadsack C, Heinemann A, Marsche G. Aging affects high-density lipoprotein composition and function. Biochim Biophys Acta. 2013;1831(9):1442–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hsu CH, Chang JB, Liu IC, Lau SC, Yu SM, Hsieh CH, et al. Mean arterial pressure is better at predicting future metabolic syndrome in the normotensive elderly: a prospective cohort study in Taiwan. Prev Med. 2015;72:76–82.

    Article  PubMed  Google Scholar 

  • Huang J, Frohlich J, Ignaszewski AP. The impact of dietary changes and dietary supplements on lipid profile. Can J Cardiol. 2011;27(4):488–505.

    Article  CAS  PubMed  Google Scholar 

  • Huang CY, Huang HL, Yang KC, Lee LT, Yang WS, Huang KC, et al. Serum triglyceride levels independently contribute to the estimation of visceral fat amount among nondiabetic obese adults. Medicine. 2015;94(23):e965.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ihm J, Quinn DM, Busch SJ, Chataing B, Harmony JA. Kinetics of plasma protein-catalyzed exchange of phosphatidylcholine and cholesteryl ester between plasma lipoproteins. J Lipid Res. 1982;23(9):1328–41.

    CAS  PubMed  Google Scholar 

  • Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990;323(18):1234–8.

    Article  CAS  PubMed  Google Scholar 

  • Ishiguro N, Maeda K, Saito A, Kishimoto W, Matsushima S, Ebner T, et al. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Drug Metab Dispos. 2008;36(4):796–805.

    Article  CAS  PubMed  Google Scholar 

  • James RW, Deakin SP. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function. Adv Exp Med Biol. 2010;660:173–81.

    Article  CAS  PubMed  Google Scholar 

  • Janikula M. Policosanol: a new treatment for cardiovascular disease?(Policosanol). Altern Med Rev. 2002;7(3):203–18.

    PubMed  Google Scholar 

  • Jargin SV. Discussion of evaluation of cholesterol-lowering and antioxidant properties of sugar cane policosanols in hamsters and humans. Appl Physiol Nutr Metab = Physiologieappliquee, nutrition etmetabolisme. 2009;34(1):75.. discussion 6–7

    Article  CAS  Google Scholar 

  • Joseph P. Alternative therapies. Am J Health-Syst Pharm: AJHP. 2003;60:1112–4.

    Article  Google Scholar 

  • Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y, et al. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension (Dallas, Tex: 1979). 1990;16(5):484–90.

    Article  CAS  Google Scholar 

  • Karadag AS, Tutal E, Ertugrul DT. Insulin resistance is increased in patients with vitiligo. Acta Derm Venereol. 2011;91(5):541–4.

    Article  CAS  PubMed  Google Scholar 

  • Kashyap SR, Osme A, Ilchenko S, Golizeh M, Lee K, Wang S, et al. Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes. J Clin Endocrinol Metab. 2018;103(2):388–96.

    Article  PubMed  Google Scholar 

  • Kassis AN, Jones PJ. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. Am J Clin Nutr. 2006;84(5):1003–8.

    Article  CAS  PubMed  Google Scholar 

  • Kassis AN, Jones PJ. Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial. Lipids Health Dis. 2008;7(1):17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kassis AN, Marinangeli CP, Jain D, Ebine N, Jones PJ. Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters. Atherosclerosis. 2007;194(1):153–8.

    Article  CAS  PubMed  Google Scholar 

  • Kassis AN, Kubow S, Jones PJ. Sugar cane policosanols do not reduce LDL oxidation in hypercholesterolemic individuals. Lipids. 2009;44(5):391–6.

    Article  CAS  PubMed  Google Scholar 

  • Kastelein JJ, Besseling J, Shah S, Bergeron J, Langslet G, Hovingh GK, et al. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study. Lancet (London, England). 2015;385(9983):2153–61.

    Article  CAS  Google Scholar 

  • Kaup RM, Khayyal MT, Verspohl EJ. Antidiabetic effects of a standardized Egyptian rice bran extract. Phytother Res: PTR. 2013;27(2):264–71.

    Article  CAS  PubMed  Google Scholar 

  • Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Women’s Health. 2004;13(10):1148–64.

    Article  Google Scholar 

  • Khalil A, Jay-Gerin JP, Fulop T Jr. Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by gamma-radiolysis of water. FEBS Lett. 1998;435(2–3):153–8.

    Article  CAS  PubMed  Google Scholar 

  • Khera AV, Rader DJ. Future therapeutic directions in reverse cholesterol transport. Curr Atheroscler Rep. 2010;12(1):73–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim S-J, Cho K-H. Blood pressure lowering effect of cuban policosanol is accompanied by improved lipoprotein profile, and HDL quality in spontaneously hypertensive rats. Atheroscler Suppl. 2018;32:128.

    Article  Google Scholar 

  • Kim Y, Lee S. Prevalence and risk factors associated with prehypertension by gender and age in a Korean population in the KNHANES 2010-2012. Iran J Public Health. 2015;44(12):1594–602.

    PubMed  PubMed Central  Google Scholar 

  • Kim JY, Seo J, Cho KH. Aspartame-fed zebrafish exhibit acute deaths with swimming defects and saccharin-fed zebrafish have elevation of cholesteryl ester transfer protein activity in hypercholesterolemia. Food Chem Toxicol. 2011;49(11):2899–905.

    Article  CAS  PubMed  Google Scholar 

  • Kim JH, Shim KW, Yoon YS, Lee SY, Kim SS, Oh SW. Cigarette smoking increases abdominal and visceral obesity but not overall fatness: an observational study. PLoS One. 2012;7(9):e45815.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim SM, Lim SM, Yoo JA, Woo MJ, Cho KH. Consumption of high-dose vitamin C (1250 mg per day) enhances functional and structural properties of serum lipoprotein to improve anti-oxidant, anti-atherosclerotic, and anti-aging effects via regulation of anti-inflammatory microRNA. Food Funct. 2015a;6(11):3604–12.

    Article  CAS  PubMed  Google Scholar 

  • Kim NH, Kwak J, Baik JY, Yoon MR, Lee JS, Yoon SW, et al. Changes in lipid substances in rice during grain development. Phytochemistry. 2015b;116:170–9.

    Article  CAS  PubMed  Google Scholar 

  • Kim JY, Lee EY, Park JK, Song YW, Kim JR, Cho KH. Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and Atherogenic process. PLoS One. 2016;11(10):e0164564.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kim JY, Kim SM, Kim SJ, Lee EY, Kim JR, Cho KH. Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects. Int J Mol Med. 2017a;39(4):889–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim SM, Lee SM, Kim SJ, Kim BJ, Shin S, Kim JR, et al. Cord and maternal sera from small neonates share dysfunctional lipoproteins with proatherogenic properties: evidence for Barker’s hypothesis. J Clin Lipidol. 2017b;11(6):1318-28.e3.

    Article  Google Scholar 

  • Kim SJ, Yadav D, Park HJ, Kim JR, Cho KH. Long-term consumption of Cuban Policosanol lowers central and brachial blood pressure and improves lipid profile with enhancement of lipoprotein properties in healthy Korean participants. Front Physiol. 2018;9:412.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep. 2008;8(1):51–9.

    Article  CAS  PubMed  Google Scholar 

  • Krauss RM, Pinto CA, Liu Y, Johnson-Levonas AO, Dansky HM. Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin. J Clin Lipidol. 2015;9(1):93–102.

    Article  PubMed  Google Scholar 

  • Kresanov P, Vasankari T, Ahotupa M, Kaikkonen J, Hutri-Kahonen N, Juonala M, et al. Paraoxonase-1 and oxidized lipoprotein lipids. The cardiovascular risk in young Finns study. Atherosclerosis. 2015;241(2):502–6.

    Article  CAS  PubMed  Google Scholar 

  • Krishna R, Anderson MS, Bergman AJ, Jin B, Fallon M, Cote J, et al. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies. Lancet (London, England). 2007;370(9603):1907–14.

    Article  CAS  Google Scholar 

  • Laaksonen DE, Niskanen L, Nyyssonen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29(20):2561–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee EY, Yoo JA, Lim SM, Cho KH. Anti-aging and tissue regeneration ability of policosanol along with lipid-lowering effect in hyperlipidemic zebrafish via enhancement of high-density lipoprotein functionality. Rejuvenation Res. 2016a;19(2):149–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee J-Y, Choi H-Y, Kang Y-R, Chang H-B, Chun H-S, Lee M-S, et al. Effects of long-term supplementation of policosanol on blood cholesterol/glucose levels and 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in a rat model fed high cholesterol diets. Food Sci Biotechnol. 2016b;25(3):899–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee JH, Jia Y, Thach TT, Han Y, Kim B, Wu C, et al. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice. Nutr Res (New York, NY). 2017a;43:89–99.

    Article  CAS  Google Scholar 

  • Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C Dyslipidemia and risks of coronary heart disease and ischemic stroke by Glycemic Dysregulation status: the strong heart study. Diabetes Care. 2017b;40(4):529–37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lemmer B, Mattes A, Bohm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension (Dallas, Tex: 1979). 1993;22(1):97–101.

    Article  CAS  Google Scholar 

  • Leong XF, Ng CY, Jaarin K. Animal models in cardiovascular research: hypertension and atherosclerosis. Biomed Res Int. 2015;2015:528757.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li WY, Wang XH, Lu LC, Li H. Discrepancy of blood pressure between the brachial artery and radial artery. World J Emerg Med. 2013;4(4):294–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lim SM, Yoo JA, Lee EY, Cho KH. Enhancement of high-density lipoprotein cholesterol functions by encapsulation of policosanol exerts anti-senescence and tissue regeneration effects via improvement of anti-glycation, anti-apoptosis, and cholesteryl ester transfer inhibition. Rejuvenation Res. 2016;19(1):59–70.

    Article  CAS  PubMed  Google Scholar 

  • Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie. 2015;116:17–23.

    Article  CAS  PubMed  Google Scholar 

  • Lin Y, Rudrum M, van der Wielen RP, Trautwein EA, McNeill G, Sierksma A, et al. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations. Metabolism. 2004;53(10):1309–14.

    Article  CAS  PubMed  Google Scholar 

  • Liu T, Wu C, He F, Yuan W, Li S, Li H, et al. Relationship between the G75A polymorphism in the apolipoprotein A1 (ApoA1) gene and the lipid regulatory effects of pravastatin in patients with hyperlipidemia. Genet Mol Res. 2016;15(2):27323196.

    Google Scholar 

  • Liu CY, Huang QF, Cheng YB, Guo QH, Chen Q, Li Y, et al. A comparative study on skin and plasma advanced Glycation end products and their associations with arterial stiffness. Pulse (Basel, Switzerland). 2017;4(4):208–18.

    Google Scholar 

  • London GM, Asmar RG, O’Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43(1):92–9.

    Article  CAS  PubMed  Google Scholar 

  • Ma A, Wang J, Yang L, An Y, Zhu H. AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice. J Lipid Res. 2017;58(8):1536–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma J, Ma L, Zhang Z, Li K, Wang Y, Chen X, et al. In vivo evaluation of insect wax for hair growth potential. PLoS One. 2018;13(2):e0192612.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension (Dallas, Tex: 1979). 2009;54(2):409–13.

    Article  CAS  Google Scholar 

  • Mahdy Ali K, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities. Br J Pharmacol. 2012;167(6):1177–94.

    Article  CAS  PubMed  Google Scholar 

  • Malkoff J. Non-invasive blood pressure for mice and rats. Animal Lab News, Kent Scientific Corporation 2005: 1–12

    Google Scholar 

  • Mandai N, Akazawa K, Hara N, Ide Y, Ide K, Dazai U, et al. Body weight reduction results in Favorable changes in blood pressure, serum lipids, and blood sugar in middle-aged Japanese persons: a 5-year interval observational study of 26,824 cases. Global J Health Sci. 2015;7(5):159–70.

    Article  Google Scholar 

  • Mani P, Uno K, St John J, Tuzcu EM, Nissen SE, Nicholls SJ. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients. Am J Cardiol. 2014;114(5):681–5.

    Article  CAS  PubMed  Google Scholar 

  • Manrique C, Lastra G, Gardner M, Sowers JR. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am. 2009;93(3):569–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, et al. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011;28(12):1105–13.

    Article  CAS  PubMed  Google Scholar 

  • Marazzi G, Pelliccia F, Campolongo G, Quattrino S, Cacciotti L, Volterrani M, et al. Usefulness of nutraceuticals (Armolipid plus) versus ezetimibe and combination in statin-intolerant patients with dyslipidemia with coronary heart disease. Am J Cardiol. 2015;116(12):1798–801.

    Article  CAS  PubMed  Google Scholar 

  • Marazzi G, Campolongo G, Pelliccia F, Quattrino S, Vitale C, Cacciotti L, et al. Comparison of low-dose statin versus low-dose statin+ Armolipid plus in high-intensity statin-intolerant patients with a previous coronary event and percutaneous coronary intervention (ADHERENCE trial). Am J Cardiol. 2017;120(6):893–7.

    Article  CAS  PubMed  Google Scholar 

  • Marinangeli CP, Kassis AN, Jain D, Ebine N, Cunnane SC, Jones PJ. Comparison of composition and absorption of sugarcane policosanols. Br J Nutr. 2007;97(2):381–8.

    Article  CAS  PubMed  Google Scholar 

  • Marsche G, Holzer M, Wolf P. Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function. Exp Dermatol. 2014;23(10):701–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mas R, Castaño G, Illnait J, Fernandez L, Fernandez J, Aleman C, et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. 1999;65(4):439–47.

    Article  CAS  PubMed  Google Scholar 

  • Materson BJ, Garcia-Estrada M, Degraff SB, Preston RA. Prehypertension is real and can be associated with target organ damage. J Am Soc Hypertens: JASH. 2017;11(11):704–8.

    Article  PubMed  Google Scholar 

  • Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res. 1995;3(Suppl 2):187s–94s.

    Article  PubMed  Google Scholar 

  • Mayer O, Seidlerova J, Filipovsky J, Vagovicova P, Wohlfahrt P, Cifkova R, et al. Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population. Hypertens Res. 2016;39(4):266–71.

    Article  CAS  PubMed  Google Scholar 

  • Mazza A, Lenti S, Schiavon L, Zuin M, D’Avino M, Ramazzina E, et al. Nutraceuticals for serum lipid and blood pressure control in hypertensive and Hypercholesterolemic subjects at low cardiovascular risk. Adv Ther. 2015;32(7):680–90.

    Article  CAS  PubMed  Google Scholar 

  • Mazzotti DR, Guindalini C, Moraes WAS, Andersen ML, Cendoroglo MS, Ramos LR, et al. Human longevity is associated with regular sleep patterns, maintenance of slow wave sleep, and favorable lipid profile. Front Aging Neurosci. 2014;6:134.

    Article  PubMed  PubMed Central  Google Scholar 

  • McCarty MF. Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. Med Hypotheses. 2002;59(3):268–79.

    Article  CAS  PubMed  Google Scholar 

  • McCarty MF. An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects. Med Hypotheses. 2005;64(3):636–45.

    Article  CAS  PubMed  Google Scholar 

  • McCarty MF. Adjuvant strategies for prevention of glomerulosclerosis. Med Hypotheses. 2006a;67(6):1277–96.

    Article  CAS  PubMed  Google Scholar 

  • McCarty MF. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med Hypotheses. 2006b;67(2):251–69.

    Article  PubMed  Google Scholar 

  • McCarty MF. Toward prevention of Alzheimers disease–potential nutraceutical strategies for suppressing the production of amyloid beta peptides. Med Hypotheses. 2006c;67(4):682–97.

    Article  CAS  PubMed  Google Scholar 

  • McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35(26):1719–25.

    Article  PubMed  PubMed Central  Google Scholar 

  • McGrowder D, Riley C, Morrison EY, Gordon L. The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer. Cholesterol. 2011;2011:496925.

    Article  PubMed  CAS  Google Scholar 

  • McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006;54(8):2541–9.

    Article  CAS  PubMed  Google Scholar 

  • McNulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens. 2007;20(3):242–7.

    Article  CAS  PubMed  Google Scholar 

  • McPherson JD, Shilton BH, Walton DJ. Role of fructose in glycation and cross-linking of proteins. Biochemistry. 1988;27(6):1901–7.

    Article  CAS  PubMed  Google Scholar 

  • McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med. 2008;7(2):48–58.

    Article  PubMed  PubMed Central  Google Scholar 

  • Menéndez R, Arruzazabala L, Más R, Del RíO A, Amor AM, GonzáLez RM, et al. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. Br J Nutr. 1997;77(6):923–32.

    Article  PubMed  Google Scholar 

  • Menéndez R, Fraga V, Amor AM, Gonzalez RM, Mas R. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation. Physiol Behav. 1999;67(1):1–7.

    Article  PubMed  Google Scholar 

  • Menéndez R, Más R, Amor AM, González RM, Fernández JC, Rodeiro I, et al. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro. Br J Clin Pharmacol. 2000;50(3):255–62.

    Article  PubMed  PubMed Central  Google Scholar 

  • Menéndez R, Más R, Amor AM, Rodeiros I, MarÍa Gonzalez R, Alfonso JL. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids. Pharmacol Res. 2001a;44(4):299–304.

    Article  PubMed  CAS  Google Scholar 

  • Menéndez R, Amor AM, Rodeiro I, Gonzalez RM, Gonzalez PC, Alfonso JL, et al. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res. 2001b;32(1):8–12.

    Article  PubMed  Google Scholar 

  • Menéndez R, Mas R, Amor AM, Ledon N, Perez J, Gonzalez RM, et al. Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D003, a mixture of very long-chain saturated fatty acids. Can J Physiol Pharmacol. 2002;80(1):13–21.

    Article  PubMed  Google Scholar 

  • Michel CC, Nanjee MN, Olszewski WL, Miller NE. LDL and HDL transfer rates across peripheral microvascular endothelium agree with those predicted for passive ultrafiltration in humans. J Lipid Res. 2015;56(1):122–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Milman S, Atzmon G, Crandall J, Barzilai N. Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. Curr Vasc Pharmacol. 2014;12(5):690–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension (Dallas, Tex: 1979). 1999;33(1 Pt 2):586–90.

    Article  CAS  Google Scholar 

  • Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006;98(11):1352–64.

    Article  CAS  PubMed  Google Scholar 

  • Mitchell GF, Lacourciere Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108(13):1592–8.

    Article  PubMed  Google Scholar 

  • Montserrat-de la Paz S, Garcia-Gimenez MD, Angel-Martin M, Perez-Camino MC, Fernandez Arche A. Long-chain fatty alcohols from evening primrose oil inhibit the inflammatory response in murine peritoneal macrophages. J Ethnopharmacol. 2014;151(1):131–6.

    Article  CAS  PubMed  Google Scholar 

  • Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17(2):118–23.

    Article  CAS  PubMed  Google Scholar 

  • Murphy KJ, Saint DA, Howe PR. Lack of effect of sugar cane and sunflower seed policosanols on plasma cholesterol in rabbits. Asia Pac J Clin Nutr. 2008;27(4):476–84.

    CAS  Google Scholar 

  • Natarajan P, Ray KK, Cannon CP. High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol. 2010;55(13):1283–99.

    Article  CAS  PubMed  Google Scholar 

  • Nawale RB, Mourya VK, Bhise SB. Non-enzymatic glycation of proteins: a cause for complications in diabetes. Indian J Biochem Biophys. 2006;43(6):337–44.

    CAS  PubMed  Google Scholar 

  • Nazratun N, Mahmood AA, Kuppusamy UR, Ahmad TS, Tan SY. Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vasc Med (London, England). 2006;11(4):245–50.

    Article  CAS  Google Scholar 

  • Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195–211.

    Article  PubMed  Google Scholar 

  • Ng CH, Leung KY, Huang Y, Chen ZY. Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters. J Agric Food Chem. 2005;53(16):6289–93.

    Article  CAS  PubMed  Google Scholar 

  • NikitinIu P, Slepchenko NV, Gratsianskii NA, Nechaev AS, Syrkin AL, Poltavskaia MG, et al. Results of the multicenter controlled study of the hypolipidemic drug polycosanol in Russia. Terapevticheskiiarkhiv. 2000;72(12):7–10.

    CAS  Google Scholar 

  • Noa M, Mas R, De La Rosa M, Magraner J. Effect of Policosanol on Lipofundin-induced atherosclerotic lesions in rats. J Pharm Pharmacol. 1995;47(4):289–91.

    Article  CAS  PubMed  Google Scholar 

  • Noa M, de la Rosa MC, Mas R. Effect of policosanol on foam-cell formation in carrageenan-induced granulomas in rats. J Pharm Pharmacol. 1996;48(3):306–9.

    Article  CAS  PubMed  Google Scholar 

  • Odden MC, Tager IB, Gansevoort RT, Bakker SJ, Fried LF, Newman AB, et al. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol. 2013;23(3):106–11.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ogier N, Amiot MJ, George S, Maillot M, Mallmann C, Maraninchi M, et al. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia. Eur J Nutr. 2013;52(2):547–57.

    Article  CAS  PubMed  Google Scholar 

  • Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K. Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride. J Clin Biochem Nutr. 2008;42(2):118–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oliaro-Bosso S, Calcio Gaudino E, Mantegna S, Giraudo E, Meda C, Viola F, et al. Regulation of HMGCoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol. Lipids. 2009;44(10):907–16.

    Article  CAS  PubMed  Google Scholar 

  • Park KH, Cho KH. High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx. J Gerontol A Biol Sci Med Sci. 2011;66(5):511–20.

    Article  PubMed  CAS  Google Scholar 

  • Park KH, Jang W, Kim KY, Kim JR, Cho KH. Fructated apolipoprotein A-I showed severe structural modification and loss of advantageous functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. Biochem Biophys Res Commun. 2010a;392(3):295–300.

    Article  CAS  PubMed  Google Scholar 

  • Park KH, Shin DG, Kim JR, Cho KH. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. J Gerontol A Biol Sci Med Sci. 2010b;65(6):600–10.

    Article  PubMed  CAS  Google Scholar 

  • Park KH, Shin DG, Kim JR, Hong JH, Cho KH. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int J Mol Med. 2010c;25(1):129–36.

    CAS  PubMed  Google Scholar 

  • Park KH, Shin DG, Cho KH. Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation. Toxicol Sci. 2014a;140(1):16–25.

    Article  CAS  PubMed  Google Scholar 

  • Park KH, Kim JM, Cho KH. Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish. Mol Nutr Food Res. 2014b;58(7):1537–45.

    Article  CAS  PubMed  Google Scholar 

  • Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004;110(17):2678–86.

    Article  CAS  PubMed  Google Scholar 

  • Perez Y, Mas R, Gonzalez RM, Jimenez S, Molina V. Effects of D-003, a mixture of very long chain saturated fatty acids, and policosanol on in vivo lipid peroxidation in rats. Arzneimittelforschung. 2008;58(3):126–30.

    CAS  PubMed  Google Scholar 

  • Pérez Y, Mas R, Oyarzábal A, Jiménez S, Molina V. Effects of policosanol (sugar cane wax alcohols) and D-003 (sugarcane wax acids) on cyclooxygenase (COX) enzyme activity in vitro. Int J Pharm Sci Rev Res. 2013;19(2):18–23.

    Google Scholar 

  • Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension (Dallas, Tex: 1979). 2006;48(6):1031–6.

    Article  CAS  Google Scholar 

  • Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104(2):191–6.

    Article  CAS  PubMed  Google Scholar 

  • Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter? Atherosclerosis. 2015;242(2):399–406.

    Article  CAS  PubMed  Google Scholar 

  • Pirro M, Mannarino MR, Bianconi V, Simental-Mendia LE, Bagaglia F, Mannarino E, et al. The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016;110:76–88.

    Article  CAS  PubMed  Google Scholar 

  • Potter LK, Sprecher DL, Walker MC, Tobin FL. Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro. J Lipid Res. 2009;50(11):2222–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Prat H, Roman O, Pino E. Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia. Revistamedica de Chile. 1999;127(3):286–94.

    CAS  Google Scholar 

  • Pravenec M, Kajiya T, Zidek V, Landa V, Mlejnek P, Simakova M, et al. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension (Dallas, Tex: 1979). 2011;57(4):731–7.

    Article  CAS  Google Scholar 

  • Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest. 2006;116(12):3090–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ranalletta M, Bierilo KK, Chen Y, Milot D, Chen Q, Tung E, et al. Biochemical characterization of cholesteryl ester transfer protein inhibitors. J Lipid Res. 2010;51(9):2739–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset alzheimer disease. Arch Neurol. 2010;67(12):1491–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rodriguez MD, Gonzalez JE, Aleman C, Rodeiro I, Arango E, Gamez R, et al. Evaluation of the reproductive and developmental toxicity of the D-003, a mixture of long-chain fatty acids, in rats and rabbits. Food Chem Toxicol. 2004;42(12):1977–85.

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Echenique C, Mesa R, Mas R, Noa M, Menéndez R, Gonzalez RM, et al. Effects of policosanol chronically administered in male monkeys (Macaca arctoides). Food Chem Toxicol. 1994;32(6):565–75.

    Article  CAS  PubMed  Google Scholar 

  • Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the strong heart study. Hypertension (Dallas, Tex: 1979). 2007;50(1):197–203.

    Article  CAS  Google Scholar 

  • Rozza F, de Simone G, Izzo R, De Luca N, Trimarco B. Nutraceuticals for treatment of high blood pressure values in patients with metabolic syndrome. High Blood Pressure Cardiovasc Prev. 2009;16(4):177–82.

    Article  CAS  Google Scholar 

  • Ruscica M, Gomaraschi M, Mombelli G, Macchi C, Bosisio R, Pazzucconi F, et al. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid plus. J Clin Lipidol. 2014;8(1):61–8.

    Article  PubMed  Google Scholar 

  • Rye KA, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2009;50(Suppl):S195–200.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Saha S, Bornstein SR, Graessler J, Kopprasch S. Crosstalk between Glycoxidative modification of low-density lipoprotein, angiotensin II-sensitization, and adrenocortical aldosterone release. Horm Metab Res. 2015;47(11):855–60.

    Article  CAS  PubMed  Google Scholar 

  • Sahebkar A, Serban MC, Gluba-Brzozka A, Mikhailidis DP, Cicero AF, Rysz J, et al. Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition (Burbank, Los Angeles County, Calif). 2016;32(11–12):1179–92.

    Article  CAS  Google Scholar 

  • Saito I, Saruta T, Kondo K, Nakamura R, Oguro T, Yamagami K, et al. Serum uric acid and the renin-angiotensin system in hypertension. J Am Geriatr Soc. 1978;26(6):241–7.

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Inigo L, Navarro-Gonzalez D, Pastrana-Delgado J, Fernandez-Montero A, Martinez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–65.

    Article  CAS  PubMed  Google Scholar 

  • Semba RD, Sun K, Schwartz AV, Varadhan R, Harris TB, Satterfield S, et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens. 2015;33(4):797–803.. discussion

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seo WD, Yuk HJ, Curtis-Long MJ, Jang KC, Lee JH, Han SI, et al. Effect of the growth stage and cultivar on policosanol profiles of barley sprouts and their adenosine 5′-monophosphate-activated protein kinase activation. J Agric Food Chem. 2013;61(5):1117–23.

    Article  CAS  PubMed  Google Scholar 

  • Serban C, Muntean D, Mikhailids DP, Toth PP, Banach M. Dysfunctional HDL: the journey from savior to slayer. Clinical lipidology. 2014;9(1):49–59.

    Article  CAS  Google Scholar 

  • Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2015;33(6):1119–27.

    Article  CAS  PubMed  Google Scholar 

  • Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol. 2004;39(1):59–66.

    Article  CAS  PubMed  Google Scholar 

  • Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension (Dallas, Tex: 1979). 2000;36(5):801–7.

    Article  CAS  Google Scholar 

  • Sesso HD, Buring JE, Chown MJ, Ridker PM, Gaziano JM. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005;165(20):2420–7.

    Article  PubMed  Google Scholar 

  • Shantha GPS, Kumar AA, Kahan S, Irukulla PK, Cheskin LJ. Triglyceride/HDL ratio as a screening tool for predicting success at reducing anti-diabetic medications following weight loss. PLoS One. 2013;8(7):e69285.

    Article  CAS  Google Scholar 

  • Sharman JE, Laurent S. Central blood pressure in the management of hypertension: soon reaching the goal? J Hum Hypertens. 2013;27(7):405–11.

    Article  CAS  PubMed  Google Scholar 

  • Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study. Hypertension (Dallas, Tex: 1979). 2013;62(6):1138–45.

    Article  CAS  Google Scholar 

  • Shepherd J. Raising HDL-cholesterol and lowering CHD risk: does intervention work? Eur Heart J Suppl. 2005;7(Suppl_F):F15–22.

    Article  CAS  Google Scholar 

  • Simic B, Hermann M, Shaw SG, Bigler L, Stalder U, Dorries C, et al. Torcetrapib impairs endothelial function in hypertension. Eur Heart J. 2012;33(13):1615–24.

    Article  CAS  PubMed  Google Scholar 

  • Singh DK, Li L, Porter TD. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther. 2006;318(3):1020–6.

    Article  CAS  PubMed  Google Scholar 

  • Sola R, Valls RM, Puzo J, Calabuig JR, Brea A, Pedret A, et al. Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial. PLoS One. 2014;9(8):e101978.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, et al. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res. 2009;104(8):952–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Streeten D, Clift G, Schletter F, Dalakos TJ. The renin-angiotensin-aldosterone system in hypertension. Ann Intern Med: AoIM. 1968;68(5):1164.

    Article  Google Scholar 

  • Suico JG, Wang MD, Friedrich S, Cannady EA, Konkoy CS, Ruotolo G, et al. Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults. J Pharm Pharmacol. 2014;66(11):1576–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sung KC, Park HY, Kim MJ, Reaven G. Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension. Cardiovasc Diabetol. 2016;15:47.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, et al. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011;17(2):30–5.

    PubMed  PubMed Central  Google Scholar 

  • Teoh CL, Griffin MD, Howlett GJ. Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein Cell. 2011;2(2):116–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in middle eastern women. J Hum Hypertens. 2012;26(9):525–32.

    Article  CAS  PubMed  Google Scholar 

  • Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, Pieber TR. Aldosterone and arterial hypertension. Nat Rev Endocrinol. 2009;6:2263.

    Google Scholar 

  • Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, et al. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol. 2010;55(19):2171–80.

    Article  CAS  PubMed  Google Scholar 

  • Torres O, Agramonte AJ, Illnait J, Mas Ferreiro R, Fernandez L, Fernandez JC. Treatment of hypercholesterolemia in NIDDM with policosanol. Diabetes Care. 1995;18(3):393–7.

    Article  CAS  PubMed  Google Scholar 

  • Trimarco V, Cimmino CS, Santoro M, Pagnano G, Manzi MV, Piglia A, et al. Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension. High Blood Pressure Cardiovasc Prev. 2012;19(3):117–22.

    CAS  Google Scholar 

  • Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension. Man Rat Circ Res. 1981;48(3):309–19.

    Article  CAS  PubMed  Google Scholar 

  • Tsai YY, Rainey WE, Bollag WB. Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production. J Endocrinol. 2017;232(2):R115–r29.

    Article  CAS  PubMed  Google Scholar 

  • Tsutsumi K, Hagi A, Inoue Y. The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biol Pharm Bull. 2001;24(5):579–81.

    Article  CAS  PubMed  Google Scholar 

  • Tziomalos K. High-density lipoprotein: quantity or quality? J Thorac Dis. 2016;8(11):2975.

    Article  PubMed  PubMed Central  Google Scholar 

  • Valdes S, Arruzazabala ML, Fernandez L, Mas R, Carbajal D, Aleman C, et al. Effect of policosanol on platelet aggregation in healthy volunteers. Int J Clin Pharmacol Res. 1996;16(2–3):67–72.

    CAS  PubMed  Google Scholar 

  • Varady KA, Wang Y, Jones PJ. Role of policosanols in the prevention and treatment of cardiovascular disease. Nutr Rev. 2003;61(11):376–83.

    Article  PubMed  Google Scholar 

  • Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351(1):33–41.

    Article  CAS  PubMed  Google Scholar 

  • Vitali C, Wellington CL, Calabresi L. HDL and cholesterol handling in the brain. Cardiovasc Res. 2014;103(3):405–13.

    Article  CAS  PubMed  Google Scholar 

  • Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31(15):1865–71.

    Article  PubMed  Google Scholar 

  • von Eckardstein A, Widmann C. High-density lipoprotein, beta cells, and diabetes. Cardiovasc Res. 2014;103(3):384–94.

    Article  CAS  Google Scholar 

  • Wang S, Kussie P, Deng L, Tall A. Defective binding of neutral lipids by a carboxyl-terminal deletion mutant of cholesteryl ester transfer protein. Evidence for a carboxyl-terminal cholesteryl ester binding site essential for neutral lipid transfer activity. J Biol Chem. 1995;270(2):612–8.

    Article  CAS  PubMed  Google Scholar 

  • Wang YW, Jones PJ, Pischel I, Fairow C. Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters. Lipids. 2003;38(2):165–70.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Ebine N, Jia X, Jones PJ, Fairow C, Jaeger R. Very long chain fatty acids (policosanols) and phytosterols affect plasma lipid levels and cholesterol biosynthesis in hamsters. Metab Clin Exp. 2005;54(4):508–14.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Chen S, Yao T, Li D, Wang Y, Li Y, et al. Homocysteine as a risk factor for hypertension: a 2-year follow-up study. PLoS One. 2014;9(10):e108223.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang ZD, Feng Y, Ma LY, Li X, Ding WF, Chen XM. Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss. Biomed Pharmacother = Biomedecine&pharmacotherapie. 2017;89:438–46.

    Article  CAS  Google Scholar 

  • Wang H-y, Q-p J, S-y C, Sheng J, Jiang H, Lu J, et al. Efficacy and safety of Policosanol plus Fenofibrate combination therapy in elderly patients with mixed Dyslipidemia: a randomized, controlled clinical study. Am J Med Sci. 2018;356(3):254–61.

    Article  PubMed  Google Scholar 

  • Weeks BS, Perez PP. PolicosanolPlus and Neuroprevin ameliorate pesticide-mediated inhibition of neurite outgrowth and neurite degeneration. Med Sci Monit. 2006;12(12):BR379–BR84.

    CAS  PubMed  Google Scholar 

  • Weiss J, Sauer A, Divac N, Herzog M, Schwedhelm E, Boger RH, et al. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters. Biopharm Drug Dispos. 2010;31(2–3):150–61.

    Article  CAS  PubMed  Google Scholar 

  • Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113(9):1213–25.

    Article  CAS  PubMed  Google Scholar 

  • Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104–9.

    Article  CAS  PubMed  Google Scholar 

  • Wong WT, Ismail M, Imam MU, Zhang YD. Modulation of platelet functions by crude rice (Oryza sativa) bran policosanol extract. BMC Complement Altern Med. 2016a;16:252.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wong WT, Ismail M, Tohit ER, Abdullah R, Zhang YD. Attenuation of thrombosis by crude Rice (Oryza sativa) bran Policosanol extract: ex vivo platelet aggregation and serum levels of Arachidonic acid metabolites. Evid Based Complement Alternat Med. 2016b;2016:7343942.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wu M, Peng Z, Zu C, Ma J, Lu S, Zhong J, et al. Losartan attenuates myocardial endothelial-to-Mesenchymal transition in spontaneous hypertensive rats via inhibiting TGF-beta/Smad Signaling. PLoS One. 2016;11(5):e0155730.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xanthakis V, Vasan RS. Aldosterone and the risk of hypertension. Curr Hypertens Rep. 2013;15(2):102–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xie D, Bollag WB. Obesity, hypertension and aldosterone: is leptin the link? J Endocrinol. 2016;230(1):F7–f11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xu K, Liu X, Li Y, Wang Y, Zang H, Guo L, et al. Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results. Cardiovasc Ther. 2016;34(5):337–42.

    Article  CAS  PubMed  Google Scholar 

  • Yadav D, Hyun DS, Ahn SV, Koh SB, Kim JY. A prospective study of the association between total sleep duration and incident hypertension. J Clin Hypertens (Greenwich). 2017;19(5):550–7.

    Article  Google Scholar 

  • Yadav D, Kim SJ, Kim JR, Cho KH. Correlation among lipid parameters, pulse wave velocity and central blood pressure in young Korean population. Clin Exp Hypertens (New York, NY: 1993). 2018a:1–8.

    Google Scholar 

  • Yadav D, Kim SJ, Bae MA, Kim JR, Cho KH. The ability of different ketohexoses to Alter Apo-A-I structure and function in vitro and to induce Hepatosteatosis, oxidative stress, and impaired plasma lipid profile in Hyperlipidemic Zebrafish. Oxidative Med Cell Longev. 2018b;2018

    Google Scholar 

  • Yamaguchi Y, Yoshikawa N, Kagota S, Nakamura K, Haginaka J, Kunitomo M. Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide Biol Chem. 2006;15(4):380–6.

    Article  CAS  Google Scholar 

  • Yanai H, Katsuyama H, Hamasaki H, Abe S, Tada N, Sako A. Effects of dietary fat intake on HDL metabolism. J Clin Med Res. 2015;7(3):145–9.

    Article  CAS  PubMed  Google Scholar 

  • Yang S, Chen XY, Xu XP. The relationship between lipoprotein-associated phospholipase a(2), Cholesteryl Ester transfer protein and lipid profile and risk of atherosclerosis in women with Iron deficiency anaemia. Clin Lab. 2015;61(10):1463–9.

    CAS  PubMed  Google Scholar 

  • Yang B, Fan S, Zhi X, He J, Ma P, Yu L, et al. Interactions of homocysteine and conventional predisposing factors on hypertension in Chinese adults. J Clin Hypertens (Greenwich). 2017;19(11):1162–70.

    Article  CAS  Google Scholar 

  • Yasmin, Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM. 1999;92(10):595–600.

    Article  CAS  PubMed  Google Scholar 

  • Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79(6):1358–64.

    Article  PubMed  Google Scholar 

  • Yoon JH, Cho KH. A point mutant of apolipoprotein A-I (V156K) showed enhancement of cellular insulin secretion and potent activity of facultative regeneration in zebrafish. Rejuvenation Res. 2012;15(3):313–21.

    Article  CAS  PubMed  Google Scholar 

  • Yu Y, Lyons TJ. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci. 2005;330(5):227–32.

    Article  PubMed  Google Scholar 

  • Yuk HJ, Ryu HW, Kim DY, Park MH, Seo WD, Jeong SH, et al. Comparison of flavonoid and policosanol profiles in Korean winter-spinach (Spinaciaoleracea L.) cultivated in different regions. Food Chem. 2019;279:202–8.

    Article  CAS  PubMed  Google Scholar 

  • Zachariah JP, Pencina MJ, Lyass A, Kaur G, D’Agostino RB, Ordovas JM, et al. Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community. J Hypertens. 2011;29(5):863–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zacharieva S, Kirilov G, Orbetzova M, Elenkova A, Shigarminova R, Lozanov V, et al. Homocysteine, renin and aldosterone in patients with Cushing’s syndrome. Methods Find Exp Clin Pharmacol. 2008;30(3):221–4.

    Article  CAS  PubMed  Google Scholar 

  • Zanardi M, Quirico E, Benvenuti C, Pezzana A. Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer. Minerva Ginecol. 2012;64(5):431–5.

    CAS  PubMed  Google Scholar 

  • Zhang M, Charles R, Tong H, Zhang L, Patel M, Wang F, et al. HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation. Sci Rep. 2015;5:8741.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, et al. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of beta cell function in a Chinese population with different glucose tolerance status. Lipids Health Dis. 2016;15:104.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. LipoLab, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, South Korea

    Kyung-Hyun Cho

Authors
  1. Kyung-Hyun Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cho, KH. (2019). Enhancement of HDL by Policosanol. In: High-Density Lipoproteins as Biomarkers and Therapeutic Tools. Springer, Singapore. https://doi.org/10.1007/978-981-13-7383-1_3

Download citation

Publish with us

Policies and ethics

Search

Navigation